Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 08:53 am Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | Deep Track Capital LP | 2,044,507 6.79% | -793,311 (-27.95%) | View |
| 2024-02-14 08:52 am Sale | 13G | RAPT THERAPEUTICS INC RAPT | Deep Track Capital LP | 1,793,966 5.22% | -197,437 (-9.91%) | View |
| 2024-02-14 08:52 am Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | Deep Track Capital LP | 5,750,000 9.6% | 2,645,493 (+85.21%) | View |
| 2024-02-14 08:51 am Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 2,997,830 6.18% | 280,659 (+10.33%) | View |
| 2024-02-14 08:50 am Purchase | 13G | NEKTAR THERAPEUTICS NKTR | Deep Track Capital LP | 18,400,000 9.65% | 6,097,763 (+49.57%) | View |
| 2024-02-14 08:50 am Sale | 13G | JOUNCE THERAPEUTICS INC. JNCE | Deep Track Capital LP | 0 0% | -4,259,653 (Position Closed) | View |
| 2024-02-14 08:49 am Sale | 13G | IVERIC BIO INC ISEE | Deep Track Capital LP | 0 0% | -7,878,119 (Position Closed) | View |
| 2024-02-14 08:48 am Sale | 13G | INOZYME PHARMA INC INZY | Deep Track Capital LP | 0 0% | -3,250,000 (Position Closed) | View |
| 2024-02-14 08:47 am Sale | 13G | IMMUNOVANT INC IMVT | Deep Track Capital LP | 1,000,000 0.69% | -8,710,000 (-89.70%) | View |
| 2024-02-14 08:47 am Sale | 13G | IMMUNIC INC IMUX | Deep Track Capital LP | 0 0% | -4,022,989 (Position Closed) | View |
| 2024-02-14 08:46 am Sale | 13G | HERON THERAPEUTICS INC HRTX | Deep Track Capital LP | 0 0% | -12,232,267 (Position Closed) | View |
| 2024-02-14 08:45 am Unchanged | 13G | HILLEVAX INC HLVX | Deep Track Capital LP | 2,900,000 5.99% | 0 (Unchanged) | View |
| 2024-02-14 08:45 am Sale | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | Deep Track Capital LP | 900,000 0.66% | -7,040,346 (-88.67%) | View |
| 2024-02-14 08:44 am Purchase | 13G | GERON CORP GERN | Deep Track Capital LP | 29,583,449 5.45% | 5,560,566 (+23.15%) | View |
| 2024-02-14 08:43 am Sale | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Deep Track Capital LP | 2,284,372 5.34% | -372,529 (-14.02%) | View |
| 2024-02-14 08:43 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | Deep Track Capital LP | 2,537,176 4% | -837,218 (-24.81%) | View |
| 2024-02-14 08:42 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Deep Track Capital LP | 0 0% | -6,345,790 (Position Closed) | View |
| 2024-02-14 08:40 am Purchase | 13G | EDITAS MEDICINE INC EDIT | Deep Track Capital LP | 5,473,086 6.7% | 979,670 (+21.80%) | View |
| 2024-02-14 08:39 am Sale | 13G | DYNE THERAPEUTICS INC DYN | Deep Track Capital LP | 2,000,000 3.26% | -2,500,000 (-55.56%) | View |
| 2024-02-14 08:39 am Purchase | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | Deep Track Capital LP | 7,093,214 5.49% | 537,034 (+8.19%) | View |